Sk Biopharmaceuticals Co., Ltd. (326030)
Market Open
9 Dec, 06:30
KRX SM KRX SM Primary ₩
134,600. 00
+1,300
+0.98%
₩
10.95T Market Cap
- P/E Ratio
0% Div Yield
48,814 Volume
566.84 Eps
₩ 133,300
Previous Close Day Range
133,200 135,600
Year Range
86,900 144,100
Want to track 326030 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 57 days
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| 326030 Sk Biopharmaceuticals Co., Ltd. 5 Feb 2026 (In 1 month) | | 354.06 | - |
| 326030 Sk Biopharmaceuticals Co., Ltd. 4 Feb 2026 (In 1 month) | | - | - |
| 326030 Sk Biopharmaceuticals Co., Ltd. 13 Nov 2025 | | 342.46 | 947 |
| 326030 Sk Biopharmaceuticals Co., Ltd. 7 Nov 2025 | | 342.46 | - |
| 326030 Sk Biopharmaceuticals Co., Ltd. 6 Nov 2025 | | - | - |
| 326030 Sk Biopharmaceuticals Co., Ltd. 6 Aug 2025 | | - | - |
| 326030 Sk Biopharmaceuticals Co., Ltd. 7 May 2025 | | 267.84 | 298 |
| 326030 Sk Biopharmaceuticals Co., Ltd. 27 Jan 2025 | | - | - |
| 326030 Sk Biopharmaceuticals Co., Ltd. 7 Nov 2024 | | 123.44 | 123 |
| 326030 Sk Biopharmaceuticals Co., Ltd. 12 Aug 2024 | | 87.9 | - |
| 326030 Sk Biopharmaceuticals Co., Ltd. 13 May 2024 | | 46.28 | - |
| 326030 Sk Biopharmaceuticals Co., Ltd. 18 Mar 2024 | | 184 | 86.32 |
| 326030 Sk Biopharmaceuticals Co., Ltd. 29 Jan 2024 | | 184 | - |
| 326030 Sk Biopharmaceuticals Co., Ltd. 13 Nov 2023 | | - | - |
326030 Earnings Reports FAQ
What is the earnings per share (EPS) for 326030?
The current EPS is 566.84.
What is the company's earnings growth rate?
Over the past 2 years, the earnings growth rate has been approximately 997.08%, reflecting the 326030's performance and KRX SM market conditions.
When is the next earnings release date?
The next earnings release is expected to be on 2026-02-04, based on the 326030's typical earnings announcement schedule.
What were the most recent quarterly earnings?
The most recent quarterly earnings were 947.0 per share, reported on 2025-11-13. For dividend history, visit the 326030 Dividends page.
What is the price-to-earnings (P/E) ratio?
The price-to-earnings (P/E) ratio is 142.13, calculated based on the most recent stock price of ₩134,600.00.
2025 © Marketlog. All Rights Reserved.
